UPDATED Apr 25, 2024
Over $1bn in market cap, profitable and undervalued based on cash flows.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MSFT | US$399.04 | -1.3% | 30.9% | US$3.0t | US$471.24 | PE35.9x | E12.6% | 0.8% | Software | ||
GOOGL | US$156.00 | -0.006% | 45.0% | US$2.0t | US$166.83 | PE26.3x | E11.9% | n/a | Media | ||
AMZN | US$173.67 | -3.1% | 58.1% | US$1.8t | US$210.59 | PE59.4x | E21.6% | n/a | Retail | ||
META | US$441.38 | -12.0% | 85.0% | US$1.3t | US$524.32 | PE24.5x | E12.2% | 0.5% | Media | ||
LLY | US$724.87 | -2.8% | 85.7% | US$659.5b | US$813.32 | PE124.6x | E27.2% | 0.7% | Pharmaceuticals & Biotech | ||
2330 | NT$766.00 | -4.7% | 55.2% | NT$19.9t | NT$912.98 | PE23.2x | E16.1% | 1.8% | Semiconductors | ||
AVGO | US$1,294.42 | 2.8% | 109.3% | US$582.4b | US$1,500.96 | PE51.8x | E23.4% | 1.6% | Semiconductors | ||
NOVO B | kr.866.80 | 0.5% | 55.2% | kr.3.9t | kr.904.20 | PE46.2x | E14.7% | 1.1% | Pharmaceuticals & Biotech | ||
JPM | US$193.37 | 6.7% | 41.1% | US$554.5b | US$206.47 | PB1.8x | E-1.5% | 2.4% | Banks | ||
WMT | US$60.21 | 1.6% | 19.3% | US$482.4b | US$65.08 | PE31.3x | E10.7% | 1.4% | Consumer Retailing | ||
XOM | US$121.33 | 2.4% | 3.9% | US$479.1b | US$130.39 | PE13.3x | E-0.6% | 3.1% | Energy | ||
UNH | US$493.86 | 0.1% | 0.7% | US$448.4b | US$567.36 | PE29.6x | E19.7% | 1.5% | Healthcare | ||
700 | HK$339.40 | 11.5% | -1.6% | HK$3.2t | HK$417.66 | PE25.4x | E15.0% | 1.0% | Media | ||
PG | US$162.55 | 3.3% | 3.9% | US$383.8b | US$169.90 | PE25.8x | E7.1% | 2.3% | Household | ||
A005930 | ₩76,300.00 | -4.1% | 18.1% | ₩508.2t | ₩101,991.89 | PE35.8x | E27.4% | 1.9% | Tech | ||
JNJ | US$146.82 | 0.7% | -9.9% | US$357.9b | US$173.60 | PE18.5x | E5.1% | 3.4% | Pharmaceuticals & Biotech | ||
HD | US$331.98 | -0.3% | 12.9% | US$330.0b | US$384.83 | PE21.7x | E4.2% | 2.7% | Retail | ||
MRK | US$130.72 | 4.4% | 13.5% | US$321.7b | US$138.58 | PE143.6x | E26.3% | 2.4% | Pharmaceuticals & Biotech | ||
COST | US$721.86 | 1.5% | 44.0% | US$320.1b | US$776.41 | PE47.1x | E7.5% | 0.6% | Consumer Retailing | ||
ORCL | US$114.89 | -1.0% | 20.9% | US$317.0b | US$137.02 | PE29.7x | E14.7% | 1.4% | Software | ||
CVX | US$165.28 | 4.9% | -1.0% | US$302.2b | US$181.37 | PE14.3x | E2.3% | 3.9% | Energy | ||
BAC | US$37.91 | 6.0% | 31.2% | US$301.5b | US$39.70 | PB1.1x | E6.2% | 2.5% | Banks | ||
ABBV | US$167.29 | 1.6% | 12.4% | US$297.1b | US$184.14 | PE61.5x | E23.4% | 3.7% | Pharmaceuticals & Biotech | ||
600519 | CN¥1,693.04 | 1.3% | -3.7% | CN¥2.1t | CN¥2,154.31 | PE28.5x | E12.8% | 3.0% | Food, Beverage & Tobacco |